Müllerian clear cell carcinoma arising from rectal endometriosis with pericolonic lymph node metastasis.

IF 3.1 3区 医学 Q1 PATHOLOGY Virchows Archiv Pub Date : 2025-05-01 Epub Date: 2024-07-08 DOI:10.1007/s00428-024-03864-y
Riley Lochner, John Nakayama, Emily Steinhagen, Christina Bagby, Min Cui
{"title":"Müllerian clear cell carcinoma arising from rectal endometriosis with pericolonic lymph node metastasis.","authors":"Riley Lochner, John Nakayama, Emily Steinhagen, Christina Bagby, Min Cui","doi":"10.1007/s00428-024-03864-y","DOIUrl":null,"url":null,"abstract":"<p><p>We present a case of clear cell carcinoma arising in endometriosis of the rectum that provides insights to the biological behavior of this extremely rare tumor. The patient presented with a large rectal mass, and the biopsy was suggestive of clear cell carcinoma of Müllerian origin based on the morphology and immunoprofile. The patient underwent a proctosigmoidectomy and hysterectomy with bilateral salpingo-oophorectomy with clear cell carcinoma involving the colon. Five pericolonic lymph nodes were positive for carcinoma. Endometriosis was identified in the colonic wall adjacent to the carcinoma. No tumor was identified in the endometrium, fallopian tubes, or ovaries. ARID1A mutations were identified by next-generation sequencing. The patient underwent adjuvant chemotherapy and is disease-free 4 years after the diagnosis. To our knowledge, this is the first case of clear cell carcinoma arising in colon endometriosis with pericolonic lymph node metastasis.</p>","PeriodicalId":23514,"journal":{"name":"Virchows Archiv","volume":" ","pages":"1073-1077"},"PeriodicalIF":3.1000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Virchows Archiv","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00428-024-03864-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/8 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

We present a case of clear cell carcinoma arising in endometriosis of the rectum that provides insights to the biological behavior of this extremely rare tumor. The patient presented with a large rectal mass, and the biopsy was suggestive of clear cell carcinoma of Müllerian origin based on the morphology and immunoprofile. The patient underwent a proctosigmoidectomy and hysterectomy with bilateral salpingo-oophorectomy with clear cell carcinoma involving the colon. Five pericolonic lymph nodes were positive for carcinoma. Endometriosis was identified in the colonic wall adjacent to the carcinoma. No tumor was identified in the endometrium, fallopian tubes, or ovaries. ARID1A mutations were identified by next-generation sequencing. The patient underwent adjuvant chemotherapy and is disease-free 4 years after the diagnosis. To our knowledge, this is the first case of clear cell carcinoma arising in colon endometriosis with pericolonic lymph node metastasis.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
直肠子宫内膜异位症引发的缪勒氏透明细胞癌伴有结肠周围淋巴结转移。
我们提出一例直肠子宫内膜异位症引起的透明细胞癌,为这种极其罕见的肿瘤的生物学行为提供了见解。患者表现为直肠大肿块,根据形态学和免疫图谱,活检提示为勒氏起源的透明细胞癌。患者行乙状结肠直肠切除术、子宫切除术及双侧输卵管卵巢切除术,并伴有结肠透明细胞癌。5个结肠周围淋巴结癌阳性。子宫内膜异位症见于癌旁的结肠壁。子宫内膜、输卵管或卵巢均未发现肿瘤。ARID1A突变通过下一代测序鉴定。患者接受了辅助化疗,诊断后4年无病。据我们所知,这是首例结肠子宫内膜异位症合并结肠周围淋巴结转移的透明细胞癌。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Virchows Archiv
Virchows Archiv 医学-病理学
CiteScore
7.40
自引率
2.90%
发文量
204
审稿时长
4-8 weeks
期刊介绍: Manuscripts of original studies reinforcing the evidence base of modern diagnostic pathology, using immunocytochemical, molecular and ultrastructural techniques, will be welcomed. In addition, papers on critical evaluation of diagnostic criteria but also broadsheets and guidelines with a solid evidence base will be considered. Consideration will also be given to reports of work in other fields relevant to the understanding of human pathology as well as manuscripts on the application of new methods and techniques in pathology. Submission of purely experimental articles is discouraged but manuscripts on experimental work applicable to diagnostic pathology are welcomed. Biomarker studies are welcomed but need to abide by strict rules (e.g. REMARK) of adequate sample size and relevant marker choice. Single marker studies on limited patient series without validated application will as a rule not be considered. Case reports will only be considered when they provide substantial new information with an impact on understanding disease or diagnostic practice.
期刊最新文献
Integrating next-generation sequencing into the routine neuroblastoma workflow identifies actionable genomic alterations and reduces low-yield karyotype testing. T-prolymphocytic leukemia with three distinct immunophenotypic subsets. Digital pathology transformation: don't forget the 'soft infrastructure' - a practice-based response from China. Correction to: Non-small cell lung carcinomas with diffuse co-expression of TTF-1 and p40: Clinical, pathological and molecular characterization of a tumor subtype. Multicenter evaluation of the Idylla IDH1-2 Mutation Assay Kit for detection of IDH mutational status in glioma.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1